In vivo studies show that rhIL-6 enhances lipolysis and fat oxidation in healthy young and elderly humans (60, 61) and IL-6 autoantibodies appear to be involved in the pathogenesis of a subset of type 2 diabetes (122). This evidence concerns the gene IL6 and type 2 diabetes mellitus.